Anticorps Monoclonal anti-NeutraKine® IL-3
NeutraKine® IL-3 Monoclonal Antibody for Neutralization, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
Neutralization, ELISA
Conjugaison
Non conjugué
CloneNo.
3C11G7
N° de cat : 69004-1-Ig
Synonymes
Galerie de données de validation
Neutralization |
Informations sur le produit
69004-1-Ig cible NeutraKine® IL-3 dans les applications de Neutralization, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | human Humankine IL-3 protein HZ-1074 |
Nom complet | interleukin 3 (colony-stimulating factor, multiple) |
Symbole du gène | IL3 |
Identification du gène (NCBI) | 3562 |
Conjugaison | Non conjugué |
Forme | Lyophilized Powder |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS stérile. |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Informations générales
Interleukin-3 (IL-3) is a multilineage hematopoietic growth factor that promotes the proliferation, differentiation and survival of early multilineage hematopoietic progenitors. In particular, this cytokine plays a key role in stimulating the proliferation and survival of myeloid precursors. It is involved in a variety of cell activities such as cell growth, differentiation and apoptosis. This cytokine has been shown to also possess neurotrophic activity, and it may be associated with neurologic disorders (PMID: 24103757;2698876;2809196).
This antibody can be used to neutralize the bioactivity of IL-3.